Afuco™ Anti-Human TMPRSS11E ADCC Therapeutic Antibody, ADCC Enhanced
Anti-TMPRSS11E ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibody against TMPRSS11E and TMPRSS11E is highly expressed on the cell membranes of cancer cell lines in flow cytometry. This antibody exhibits antibody-dependent cell-mediated cytotoxicity activity (ADCC activity) and antitumor effect based on internalization activity and is promising as a therapeutic target. Moreover, this antibody has neutralization activity against protease activity and is also expected to have effect brought about by the inhibition of TMPRSS11E functions.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-597CL |
| Pricing | Inquiry |
| Host | Chimeric (human/mouse) |
| Target | TMPRSS11E |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage |
|